{"abstract": "The drugs, mainly for men with late-stage prostate cancer, can extend lives for additional months, but some cost more than $90,000 for a course of treatment.", "web_url": "https://www.nytimes.com/2011/06/28/health/28prostate.html", "snippet": "The drugs, mainly for men with late-stage prostate cancer, can extend lives for additional months, but some cost more than $90,000 for a course of treatment.", "lead_paragraph": "A group of new drugs is promising to prolong the lives and relieve the symptoms of men with advanced prostate cancer, but could also add billions of dollars to the nation\u2019s medical bills. ", "print_section": "A", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2011/06/28/business/PROSTATE-1/PROSTATE-1-jumbo.jpg", "height": 1024, "width": 768, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}], "headline": {"main": "New Drugs Fight Prostate Cancer, but at High Cost", "kicker": null, "content_kicker": null, "print_headline": "New Drugs Fight Prostate Cancer, But at High Cost", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Dendreon Corp", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson", "rank": 3, "major": "N"}, {"name": "subject", "value": "Prostate Cancer", "rank": 4, "major": "N"}], "pub_date": "2011-06-28T01:19:57+0000", "document_type": "article", "news_desk": "Business", "section_name": "Health", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/092a47e2-78bc-540d-9715-049ba53e1b1e", "word_count": 1162, "uri": "nyt://article/092a47e2-78bc-540d-9715-049ba53e1b1e"}